Reuters - Video

Edition: US | UK | IN | CN | JP

Finance Videos

U.S. Morning Call: A hostile drug deal may end well

Sunday, July 15, 2012 - 02:38

July 16 - GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences after a 3-month long hostile takeover battle.

▲ Hide Transcript

View Transcript

Giving hedge funds a leg up and becoming friends after all here's your morning called this Monday. Top hedge funds reportedly obtained information stock analyst headed the rest of the market which allowed to profit from it. The New York Times says 2008 and 2009. Barkley is unit now part of black rock gave. Analysts at major brokerages certain about their views on stocks which own documents described as quote trying to front run -- or recommendations. A spokesman for black rock calls the -- sloppy inaccurate and totally inconsistent with stated purpose of the survey. The paper says British hedge British hedge fund firm Marshall Wallace an American firm to -- investments. Also gave brokerages questionnaires for analysts. Looks like a hostile takeover battle will and on friendlier terms GlaxoSmithKline. Expected to announce a deal to buy Human Genome Sciences today. The two point eight billion dollar big -- and a three month pursuit of the US Biotech firm. Sources say -- should work out to fourteen dollars a share up from the earlier offer of thirteen bucks that was rejected. But texture and and that is big pharma firms seek new products replace drugs coming off patent. Friday strong market performance not doing much for stocks today. Dow NASDAQ S&P 500 stocks index futures indicating a lower open when trading starts about two hours. Results from Citigroup and June retail sales among the market events that could provide more direction. European stocks flat to lower with the Euro trading near 120. -- New York State and connect it to the list of groups launching investigations in to -- apartment here. The manipulation. A spokesman for a New York attorney general Eric Schneider in saying the state. Start pro with Connecticut six months ago. The Justice Department also looking into the manipulation of the key interest rate -- New York Times. So far Barclays has agreed to pay more than 450. Million dollars in fines for its role in the scandal. And finally a couple of stocks to watch starting with Nokia the Finnish cell phone company cutting the price of its Lumia 900 windows -- and half. To try to boost sales. And Thermo scientific ESP 500 stock buy privately held transplant diagnostics arm for 925. It. That your morning called this Monday you can follow us on Twitter at Reuters Insider. And please check out our Reuters YouTube channel Reuters dot com slash Reuters TV I'm Lisa Bernhard this is Reuters.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

U.S. Morning Call: A hostile drug deal may end well

Sunday, July 15, 2012 - 02:38